SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 6, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The insider cluster is too small to warrant a directional read. Monitor for larger insider activity or upcoming earnings/catalyst events that might drive more meaningful insider behavior.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$168.48
T+0 close · Aug 6, 2026 · via day close
Latest settled
+6.13%
T+60 · $178.80
Vs SPY
+8.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 7 $168.48entry
  2. T+1 · 3mo ago −0.75%α −0.72% · $167.21
  3. T+5 · 3mo ago −7.20%α −7.60% · $156.35
  4. T+20 · 2mo ago −4.20%α −3.80% · $161.41
  5. T+60 · 15d ago +6.13%α +8.39% · $178.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Guardant Health directors (Ian T. Clark and Manuel Hidalgo Medina) sold a combined $1.60M in open-market shares over two days, primarily from exercised derivatives. The total sale value represents only ~0.007% of GH's $21.9B market cap, a trivial amount that does not signal a material change in insider conviction or company outlook.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
2

Key Facts

  • Two directors sold a combined $1.60M in open-market shares (Clark: $1.44M, Hidalgo Medina: $156K).
  • Sales represent ~0.007% of GH's $21.9B market cap, well below the 0.1% materiality threshold.
  • Both sales were accompanied by derivative exercises (non-cash grants), indicating routine portfolio management.
  • No C-suite executives participated; all trades were by directors.

Financial Impact

Total open-market sales of $1.60M, immaterial relative to $21.9B market cap.

insider holdings

Risk Factors

  • Insider sales at elevated stock price could precede a pullback, but scale is too small to be predictive.
  • No C-suite participation reduces signal value of the cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
91% bullish (35 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GH-1786050409906

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026